Fundraising Fox

Synnovation Therapeutics

Wilmington, US · Founded 2021 · Delaware corporation · 3 known investors

synnovationtx.com ↗

A drug discovery company founded by an experienced medicinal chemistry team with expertise in successful pharmaceutical development and clinical advancement.

BiotechDeep TechMedical Devicesin /synnovationtx

Founders & leadership

LW
Liangxing WuExecutive Officer, Director
RH
Reid HuberDirector
TF
Ting FengDirector
WY
Wenqing YaoExecutive Officer, Director

Investors · 3

Nextech InvestZurich · $648K – $3.2M
The Innovation SpaceWilmington · $200K
Third Rock VenturesBoston · $100K – $5M

Reported raises · per SEC filings

Form D private placements
▶$15MraisedDec 2023 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Liangxing WuExecutive Officer, Director
  • Wenqing YaoExecutive Officer, Director
  • Reid HuberDirector
  • Ting FengDirector
Offering amount
$102.5M
Amount sold
$15M
First sale
Dec 2023
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$25MraisedMay 2023 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Liangxing WuExecutive Officer, Director
  • Reid HuberDirector
  • Ting FengDirector
  • Wenqing YaoExecutive Officer, Director
Offering amount
$25M
Amount sold
$25M
First sale
May 2023
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12MraisedNov 2021 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Wenqing YaoExecutive Officer, Director
  • Liangxing WuExecutive Officer, Director
Offering amount
$20M
Amount sold
$12M
First sale
Nov 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news